Dr. David G. Hwang, MD

Dr. Hwang practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Hwang's NPI, 1346292224, was assigned on May 17, 2006. Dr. Hwang graduated from UCSF School of Medicine in 1984. Dr. Hwang's California license number on file is G56748.

Dr. Hwang's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Hwang's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Hwang to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hwang practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Hwang's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Hwang is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Hwang has a license on file in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, eye infection or inflammation, glaucoma and glaucoma surgery among the conditions Dr. Hwang treats.

CMS data shows 1,261 Medicare services from Dr. Hwang across 13 procedure codes in 2024, for 455 Medicare patients. Medicare paid $149,815 for them.

CMS counts 455 Medicare patients who saw Dr. Hwang in 2024. The largest group is 75 to 84, with 211 patients. 74% of them have high cholesterol, and 65% have high blood pressure. 16% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hwang's median patient age at 77, with 57% women.

In 2024, Dr. Hwang wrote 1,690 Medicare Part D claims for 332 patients. 54% of them were for generic drugs. CMS names the drug for 1,549 of them, across 16 drugs with 11 or more claims each, at $83,033 in total drug cost. In 2023, CMS named 1,907 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Hwang for performance year 2024, reported as part of a group. Dr. Hwang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 77 procedures of cataract surgery by Dr. Hwang, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 48 papers to Dr. Hwang, published from 2006 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Cornea, Corneal Stroma and Keratitis. Dr. Hwang has published most often in Am J Ophthalmol. Dr. Hwang's most frequent co-authors are Matilda F. Chan, MD, PhD, Jennifer Ruth Rose-Nussbaumer, MD and Frank Lewis Brodie, MD.

CMS Open Payments shows 22 general payments to Dr. Hwang from 4 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 81% of the total. Shire North American Group Inc paid the most, $39,591.

Dmand AI lists 4 awards for Dr. Hwang, most recently Regional Top Doctor in 2014.

Dr. Hwang graduated from UCSF School of Medicine in 1984.

Dr. Hwang is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.